Lasa Supergenerics Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Omkar Herlekar
Chief executive officer
₹9.7m
Total compensation
CEO salary percentage | n/a |
CEO tenure | 8.8yrs |
CEO ownership | 53.7% |
Management average tenure | less than a year |
Board average tenure | 7.6yrs |
Recent management updates
Recent updates
Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues
Dec 10There's No Escaping Lasa Supergenerics Limited's (NSE:LASA) Muted Revenues
Aug 08We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt
Jun 05Little Excitement Around Lasa Supergenerics Limited's (NSE:LASA) Revenues As Shares Take 26% Pounding
Mar 13Improved Revenues Required Before Lasa Supergenerics Limited (NSE:LASA) Stock's 25% Jump Looks Justified
Dec 28We Think Lasa Supergenerics (NSE:LASA) Has A Fair Chunk Of Debt
Jul 05Lasa Supergenerics (NSE:LASA) Is Carrying A Fair Bit Of Debt
Mar 28Lasa Supergenerics' (NSE:LASA) Dividend Will Be ₹0.25
Sep 02Would Lasa Supergenerics (NSE:LASA) Be Better Off With Less Debt?
Aug 13A Look At The Fair Value Of Lasa Supergenerics Limited (NSE:LASA)
Jun 21Is Lasa Supergenerics (NSE:LASA) Using Too Much Debt?
Dec 06CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -₹227m |
Jun 30 2024 | n/a | n/a | -₹195m |
Mar 31 2024 | ₹10m | n/a | -₹217m |
Dec 31 2023 | n/a | n/a | -₹214m |
Sep 30 2023 | n/a | n/a | -₹249m |
Jun 30 2023 | n/a | n/a | -₹315m |
Mar 31 2023 | ₹6m | n/a | -₹386m |
Dec 31 2022 | n/a | n/a | -₹113m |
Sep 30 2022 | n/a | n/a | -₹111m |
Jun 30 2022 | n/a | n/a | -₹183m |
Mar 31 2022 | ₹2m | n/a | -₹53m |
Dec 31 2021 | n/a | n/a | -₹139m |
Sep 30 2021 | n/a | n/a | -₹26m |
Jun 30 2021 | n/a | n/a | ₹182m |
Mar 31 2021 | ₹2m | n/a | ₹228m |
Dec 31 2020 | n/a | n/a | ₹216m |
Sep 30 2020 | n/a | n/a | ₹176m |
Jun 30 2020 | n/a | n/a | ₹101m |
Mar 31 2020 | ₹2m | ₹2m | ₹36m |
Dec 31 2019 | n/a | n/a | -₹8m |
Sep 30 2019 | n/a | n/a | -₹86m |
Jun 30 2019 | n/a | n/a | -₹101m |
Mar 31 2019 | ₹4m | ₹4m | -₹120m |
Dec 31 2018 | n/a | n/a | -₹167m |
Sep 30 2018 | n/a | n/a | -₹83m |
Jun 30 2018 | n/a | n/a | ₹55m |
Mar 31 2018 | ₹4m | ₹4m | ₹123m |
Compensation vs Market: Omkar's total compensation ($USD114.05K) is above average for companies of similar size in the Indian market ($USD42.37K).
Compensation vs Earnings: Omkar's compensation has increased whilst the company is unprofitable.
CEO
Omkar Herlekar (43 yo)
8.8yrs
Tenure
₹9,690,000
Compensation
Dr. Omkar Pravin Herlekar is Non Executive & Non Independent Director of Amarnath Securities Limited from November 02, 2022. Dr. Herlekar was Director of Amarnath Securities Limited from 2019 to July 10, 2...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & MD | no data | ₹9.69m | 53.65% ₹ 774.4m | |
Company Secretary & Compliance Officer | 1.8yrs | ₹588.00k | no data | |
Additional Executive Director | less than a year | ₹52.00k | no data | |
Chief Financial Officer | less than a year | no data | no data | |
Senior Accounts Officer | no data | no data | no data | |
Manager of HR & Admin | no data | no data | no data |
0.8yrs
Average Tenure
Experienced Management: LASA's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & MD | 8.8yrs | ₹9.69m | 53.65% ₹ 774.4m | |
Additional Executive Director | less than a year | ₹52.00k | no data | |
Non-Executive & Independent Director | 6.8yrs | ₹150.00k | no data | |
Non-Executive Independent Director | 7.6yrs | ₹175.00k | no data | |
Non-Executive & Independent Director | 7.6yrs | ₹225.00k | no data | |
Non-Executive & Independent Director | 7.6yrs | ₹225.00k | no data |
7.6yrs
Average Tenure
40yo
Average Age
Experienced Board: LASA's board of directors are considered experienced (7.6 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 22:39 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Lasa Supergenerics Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|